-
Price Momentum
NVAX is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of NVAX shares has decreased $0.02 since the market last closed. This is a 0.23% drop.
-
Opened at $6.58.
The stock opened $0.01 higher than its previous close.
Key terms
About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
-
Market cap: $1.07B
A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.
Key terms
Smart score
Latest NVAX news
NVAX Financials
-
Total revenue: $682.16M (1Y), $70.44M (Q3)
Total Revenue decreased 30.65% since last year and decreased 70.55% since last quarter.
-
Net income: -$187.50M (1Y), -$202.38M (Q3)
Net Income increased 65.6% since last year and decreased 290.01% since last quarter.
-
Earnings per share: -$1.23 (1Y), -$1.25 (Q3)
EPS increased 77.22% since last year and decreased 307.4% since last quarter.
Key terms
NVAX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVAX Competitors
-
How competitors are chosen
NVAX's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.07B
A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.






